VTV250117P150000
- 0.00
- 0.000.00%
Vanguard Value ETF Newsroom
Johnson & Johnson Says Intra-Cellular Acquisition Includes CAPLYTA (Lumateperone), The First And Only US FDA-Approved Treatment For Bipolar I And II Depression As An Adjunctive And Monotherapy
Express News | Biden unveils the latest round of AI chip curbs aimed at China and Russia. Nvidia, ASML, and TSMC fall more than 2%.
Nvidia Says New Chip Rule 'Will Derail AI Progress for Industries'
Bank of America Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Watch These Stocks This Week Amid One of the Biggest Retail Conferences of the Year
Illumina Launches Proteomics Pilot With 50,000 UK Biobank Samples, Partners With GSK, J&J, and Novartis
Oil at Four-Month High Amid New Sanctions on Russia
U.S. Bank Stocks Kick Off Earnings Season! Will Trump 2.0's Regulatory Easing Propel Stock Prices to New Heights?
Moody's Assesses California's P&C, Commercial Property Insurers Amid Wildfire Disaster
Newsom: LA Wildfires Could Become Worst Natural Disaster in US History
Warren Buffett Sounds Alarm on 'Casino-Like' Market, Shares This Key Lesson for Young Investors
10 Levered Big-caps That May Face Higher Refinancing Expenses
Earnings Week Ahead: JPM, BAC, C, GS, TSM, UNH and More
California's $10 Trillion Property Market Faces Unprecedented Threat From Wildfires
Data Center Infrastructure Revenue to Reach $282B in 2024, Capacity to Triple by 2030
Notable Analyst Calls This Week: Tesla, Apple and Boeing Stocks Among Top Picks
CMS Proposes 4.33% Increase for Medicare Advantage Plans
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Wall Street Today: Labor Gains Hurt a Hurting Market
Catalyst Watch: Bank Earnings, Oil Updates, Powerhouse Conferences in Retail and Healthcare